Key result
Infant ECLS yields ~30% survival, with neurologic injuries affecting over half of survivors.
Why the study?
This study sought to evaluate survival, long-term neurologic complications, and healthcare burden in infant extracorporeal life support recipients using nationally representative single-payer administrative data.
Cohort (n=698)
Yes
Infants receiving ECLS experience high mortality (67.1% at 1 year) and a 60.4% rate of neurologic complications among survivors, driving significantly longer hospital stays and substantial long-term healthcare costs.
Answers are grounded in this paper and cite their sources.
ECLS in infants carries high mortality and morbidity risks requiring careful counseling; leaves open identification of candidates most likely to benefit in prospective studies.
Objectives: To evaluate survival, neurologic complications, and healthcare burden in infant extracorporeal life support (ECLS) recipients using nationally representative administrative data from a single-payer healthcare system. Design: Retrospective, population-based cohort study. Setting: South Korea’s National Health Insurance Service, covering 97% of the population. Patients: Infants under 1 year who received ECLS between 2009 and 2022. Interventions: None. Measurements and Main Results: Of 698 infants who underwent ECLS, 212 infants (30.4%) survived during follow-up (estimated 1-yr mortality: 67.1%). Among survivors, 128 (60.4%) developed neurologic injuries, including acute events such as ischemic stroke, hemorrhagic stroke, and hypoxic-ischemic brain injury (HIBI), as well as long-term sequelae such as cerebral palsy, epilepsy, hearing loss, and developmental delay. Most acute neurologic injuries were diagnosed within the first year, whereas developmental delay showed prolonged diagnostic windows extending up to 12 years. Survivors with neurologic injury had significantly longer hospital stays (432.1 vs. 182.3 d; p < 0.001) and higher cumulative healthcare costs during long-term follow-up. Median index hospitalization costs were USD 36,000–37,000. The burden analysis showed distinct profiles across neurologic complications: developmental delay was the most prevalent sequela, whereas HIBI was associated with the highest cumulative healthcare cost despite lower prevalence. Conclusions: Neurologic complications following ECLS in infants are common and impose substantial long-term healthcare burden. These findings highlight the need for early risk stratification, structured neurologic and neurodevelopmental monitoring, and sustained rehabilitation planning in this high-risk population. This study provides a foundation for international benchmarking and health policy planning in pediatric critical care.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2026) conducted a cohort in Infants receiving extracorporeal life support (ECLS) (n=698). Extracorporeal life support (ECLS) was evaluated on Survival and neurologic complications (acute events and long-term sequelae). Infant extracorporeal life support recipients had a 30.4% survival rate, with 60.4% of survivors developing neurologic injuries and prolonged hospital stays.
Synapse has enriched 10 related papers. Consider them for comparative context: